Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.
Effective chemical compound toxicity screening is of paramount importance for safe cardiac drug development. Using mammals in preliminary screening for detection of cardiac dysfunction by electrocardiography (ECG) is costly and requires a large number of animals. Alternatively, zebrafish embryos can...
Main Authors: | Sundeep Singh Dhillon, Eva Dóró, István Magyary, Stuart Egginton, Attila Sík, Ferenc Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23579446/?tool=EBI |
Similar Items
-
3D Finite Element Electrical Model of Larval Zebrafish ECG Signals.
by: James Crowcombe, et al.
Published: (2016-01-01) -
Recent advances and future trends in zebrafish bioassays for aquatic ecotoxicology
by: Istvan Magyary
Published: (2018-10-01) -
Prolongation of QT Interval in ECG: A Hidden Complication of Cirrhotic Liver Disease
by: Ajeet Kumar, et al.
Published: (2019-03-01) -
QT Interval Prolongation in Patients with Systemic Sclerosis—Are the Holter ECG Recordings a Better Option for QT Interval Evaluation?
by: Elena E. Saramet, et al.
Published: (2021-03-01) -
Blood Vessel Imaging at Pre-Larval Stages of Zebrafish Embryonic Development
by: Alexander S. Machikhin, et al.
Published: (2020-10-01)